Immune Response Corporation (OTCBB: IMNR)
IMNR is down over 65% today following announcement that a registration is effective.
We see it as too great a sell-off for the quality of the company.
We may be buying shares in the market today, although as of this alert we have bought no shares and have no orders pending.
Disclosure: Pentony Enterprises LLC was compensated $17,500 from ROI Group Associates Inc. for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.